Archive for 'Tag Archives: 'Clinical Studies''

Breast International Group (BIG) selects OncoDNA for multi-year analysis research program AURORA

Breast International Group (BIG) selects OncoDNA for multi-year analysis research program AURORA

At the recently held conference hosted by OncoDNA in the IPG building (Gosselies, Belgium) Jean-Pol Detiffe (CEO, OncoDNA) and Martine Piccart (Co-founder and chair, BIG) announced the launch of a multi-year analysis program AURORA, conducted by [...]

CluePoints holds official inauguration* of new office in Mont Saint Guibert and launches solution for risk-based monitoring using the SMART™ engine approach

CluePoints holds official inauguration* of new office in Mont Saint Guibert and launches solution for risk-based monitoring using the SMART™ engine approach

IDDI (International Drug Development Institute) has recently launched its subsidiary entitled CluePoints, the new software and service provider of Intelligent Statistical Monitoring Solutions. This exciting new development is a follow-up to the IDDI article published last [...]

Euroscreen UPDATE: Euroscreen completes €10 million financing round!

Euroscreen UPDATE: Euroscreen completes €10 million financing round!

Euroscreen has recently announced the completion of a €10 million Series A preferred stock financing led by Vesalius Biocapital II Partners and SRIW(Société Régionale d’Investissement de Wallonie SA). The proceeds of the round will mainly be used to fund and develop the [...]

Euroscreen(Gosselies,Belgium): selling “Euroscreen FAST” to focus on state-of-the-art small molecule drug therapeutics

Euroscreen(Gosselies,Belgium): selling “Euroscreen FAST” to focus on state-of-the-art small molecule drug therapeutics

Euroscreen, a spin-off of ULB with plans of establishing a treatment for endometriosis*, is putting its “services business unit” up for sale. Recognizing the need for capital increases like the other active companies in the biotechnologies [...]

Celebrating 20 years of Phase 1 clinical studies in Belgium, Pfizer Clinical Research Unit Brussels (PCRUB) launches appeal for partnership.

Celebrating 20 years of Phase 1 clinical studies in Belgium, Pfizer Clinical Research Unit Brussels (PCRUB) launches appeal for partnership.

As Pfizer Clinical Research Unit Brussels (PCRUB) celebrates its 20 years of research and development of new drugs Pfizer launches an appeal to all universities and partners in the healthcare sector in efforts to restore the [...]